GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (NEOE:PFE) » Definitions » Cyclically Adjusted Book per Share

Pfizer (NEOE:PFE) Cyclically Adjusted Book per Share : C$6.99 (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Pfizer Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Pfizer's adjusted book value per share for the three months ended in Mar. 2025 was C$7.747. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is C$6.99 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Pfizer's average Cyclically Adjusted Book Growth Rate was 2.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 5.10% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 5.00% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 3.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Pfizer was 27.40% per year. The lowest was 0.90% per year. And the median was 8.00% per year.

As of today (2025-05-27), Pfizer's current stock price is C$10.85. Pfizer's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was C$6.99. Pfizer's Cyclically Adjusted PB Ratio of today is 1.55.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pfizer was 4.70. The lowest was 1.44. And the median was 2.89.


Pfizer Cyclically Adjusted Book per Share Historical Data

The historical data trend for Pfizer's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Cyclically Adjusted Book per Share Chart

Pfizer Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 6.22 6.62 6.83 6.94

Pfizer Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.96 6.96 6.96 6.94 6.99

Competitive Comparison of Pfizer's Cyclically Adjusted Book per Share

For the Drug Manufacturers - General subindustry, Pfizer's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pfizer's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Pfizer's Cyclically Adjusted PB Ratio falls into.


;
;

Pfizer Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pfizer's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=7.747/134.9266*134.9266
=7.747

Current CPI (Mar. 2025) = 134.9266.

Pfizer Quarterly Data

Book Value per Share CPI Adj_Book
201506 4.552 100.684 6.100
201509 4.876 100.392 6.553
201512 4.879 99.792 6.597
201603 4.573 100.470 6.141
201606 4.529 101.688 6.009
201609 4.642 101.861 6.149
201612 4.442 101.863 5.884
201703 4.459 102.862 5.849
201706 4.429 103.349 5.782
201709 4.250 104.136 5.507
201712 5.170 104.011 6.707
201803 5.180 105.290 6.638
201806 5.304 106.317 6.731
201809 5.459 106.507 6.916
201812 5.059 105.998 6.440
201903 4.803 107.251 6.042
201906 4.832 108.070 6.033
201909 5.291 108.329 6.590
201912 5.101 108.420 6.348
202003 5.551 108.902 6.878
202006 5.331 108.767 6.613
202009 5.276 109.815 6.482
202012 4.941 109.897 6.066
202103 5.236 111.754 6.322
202106 5.191 114.631 6.110
202109 5.804 115.734 6.766
202112 5.971 117.630 6.849
202203 6.338 121.301 7.050
202206 6.780 125.017 7.317
202209 7.477 125.227 8.056
202212 7.858 125.222 8.467
202303 8.311 127.348 8.806
202306 7.914 128.729 8.295
202309 7.889 129.860 8.197
202312 7.183 129.419 7.489
202403 7.485 131.776 7.664
202406 7.203 132.554 7.332
202409 7.492 133.029 7.599
202412 7.530 133.157 7.630
202503 7.747 134.927 7.747

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Pfizer  (NEOE:PFE) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Pfizer's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=10.85/6.99
=1.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pfizer was 4.70. The lowest was 1.44. And the median was 2.89.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Pfizer Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Pfizer's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Pfizer Business Description

Industry
Address
66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.